Who Paid My Doc
Prodromal to Mild Ad
Research payments
$6,441,466
Through program year 2022, $6,441,466 in research payments was reported against Prodromal to Mild Ad, across 665 payments, paid by Genentech, Inc..
- Paid by
- Genentech, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $18,781 | 1 |
| 2021 | Research | $49,638 | 6 |
| 2020 | Research | $294,164 | 49 |
| 2019 | Research | $6,078,883 | 609 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- John Nardandrea Ocala, FL Named on 26 payments
- John Scott Richmond, VA Named on 25 payments
- David Watson Temple Terrace, FL Named on 23 payments
- Bart Sloan Norwalk, CT Named on 21 payments
- Alexander White Port Orange, FL Named on 19 payments
- Sanjiv Sharma Toms River, NJ Named on 17 payments
- William McElveen Columbia, SC Named on 16 payments
- John Olichney Sacramento, CA Named on 15 payments
- Adam Boxer San Francisco, CA Named on 14 payments
- Oleg Tcheremissine Charlotte, NC Named on 13 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.